Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gene Therapy

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3302295PMID 15215884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Titer determination of Ad5 in blood: a cautionary note

  2003cited by this paper
• Adenovirus Serotype 5 Fiber Shaft Influences In Vivo Gene Transfer in Mice

  2003cited by this paper
• In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.

  2002cited by this paper
• Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

  2001cited by this paper
• Reducing the Native Tropism of Adenovirus Vectors Requires Removal of both CAR and Integrin Interactions

  2001cited by this paper
• Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5

  2001cited by this paper
• Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism

  2001cited by this paper
• Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver.

  2001cited by this paper
• Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies

  2001cited by this paper
• CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

  2001cited by this paper
• Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

  2001cited by this paper
• Targeting adenovirus

  2000cited by this paper
• Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia.

  2000cited by this paper
• Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display.

  2000cited by this paper
• Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions.

  2000cited by this paper
• Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney.

  2000cited by this paper
• Quantitation of adenovirus DNA and virus particles with the PicoGreen fluorescent Dye.

  1999cited by this paper
• Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.

  1999cited by this paper
• Modification of an Adenoviral Vector with Biologically Selected Peptides: A Novel Strategy for Gene Delivery to Cells of Choice

  1999cited by this paper
• The Murine CAR Homolog Is a Receptor for Coxsackie B Viruses and Adenoviruses

  1998cited by this paper
• Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5

  1997cited by this paper
• Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment

  1993cited by this paper
• Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

  1993cited by this paper
• Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro.

  1989cited by this paper

• Extracellular vesicles as missiles for enhanced anti-tumor efficacy of oncolytic viruses: from disseminating oncolysis and anti-tumor immunity to targeted delivery

  2025cites this paper
• The Immune System—A Double-Edged Sword for Adenovirus-Based Therapies

  2024cites this paper
• Rational selection of an ideal oncolytic virus to address current limitations in clinical translation.

  2023cites this paper
• Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer

  2023cites this paper
• Viral protein nanoparticles (Part 1): pharmaceutical characteristics.

  2023cites this paper
• Progress in oncolytic viruses modified with nanomaterials for intravenous application

  2023cites this paper
• Oncolytic Viruses and Cancer Immunotherapy

  2022cites this paper
• Nucleic Acid Delivery to the Vascular Endothelium.

  2022cites this paper
• Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream

  2022cites this paper
• Bionanoparticles in cancer imaging, diagnosis, and treatment

  2022cites this paper
• Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions

  2022cites this paper
• Nanomedicine for advanced cancer immunotherapy.

  2022cites this paper
• Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses

  2022cites this paper
• Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements

  2021cites this paper
• Less phagocytosis of viral vectors by tethering with CD47 ectodomain.

  2021cites this paper
• Metallic Nanoparticle-Mediated Immune Cell Regulation and Advanced Cancer Immunotherapy

  2021cites this paper
• Pharmacokinetics and tolerance of repeated oral administration of 5-fluorocytosine in healthy dogs

  2021cites this paper
• Oncolytic virus therapy in cancer: A current review

  2021cites this paper
• Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus

  2021cites this paper
• ADME of Biologicals and New Therapeutic Modalities

  2021cites this paper
• Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors

  2021cites this paper
• Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy

  2021cites this paper
• Methods for Modification of Therapeutic Viruses.

  2020cites this paper
• Investigating the Effect of Encapsulation Processing Parameters on the Viability of Therapeutic Viruses in Electrospraying

  2020cites this paper
• Oncolytic Viruses

  2020cites this paper
• Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors

  2020cites this paper
• Materials promoting viral gene delivery.

  2020cites this paper
• Retargeting adenoviruses for therapeutic applications and vaccines

  2020cites this paper
• Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer

  2020cites this paper
• A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)

  2020cites this paper
• Exploring the Functions of Polymers in Adenovirus-Mediated Gene Delivery: Evading Immune Response and Redirect Tropism

  2019cites this paper
• Polyethylenimine (PEI)-Mediated E1A Increases the Sensitivity of Hepatocellular Carcinoma Cells to Chemotherapy

  2019cites this paper
• Plant/Bacterial Virus-Based Drug Discovery, Drug Delivery, and Therapeutics

  2019cites this paper
• Exploring the Functions of polymers in adenovirus-mediated gene delivery: evading immune response and redirecting tropism.

  2019cites this paper
• Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo.

  2019cites this paper
• Achieving systemic delivery of oncolytic viruses

  2019cites this paper
• Virus oncolíticos: un arma contra el cáncer

  2019cites this paper
• Sequential post-polymerization modification of a pentafluorophenyl ester-containing homopolymer: a convenient route to effective pH-responsive nanocarriers for anticancer drugs.

  2019cites this paper
• Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances

  2019cites this paper
• Development of PEG-peptide scavenger receptor inhibitors for non-viral gene delivery: an in-depth analysis into the properties which influence liver uptake

  2018cites this paper
• Nanointerventions for Gene Therapy

  2018cites this paper
• Polymer‐coated viral vectors: hybrid nanosystems for gene therapy

  2018cites this paper
• Oncolytic Viruses: A Gene Therapy for Treatment of Cancer in Companion Animals

  2018cites this paper
• Antibody-pHPMA functionalised fluorescent silica nanoparticles for colorectal carcinoma targeting

  2018cites this paper
• Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo

  2018cites this paper
• Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization

  2017cites this paper
• Systemic virotherapy for multiple myeloma

  2017cites this paper
• Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect

  2017cites this paper
• Barriers to systemic application of virus-based vectors in gene therapy: lessons from adenovirus type 5

  2017cites this paper
• Development of ovarian cancer-targeted adenoviral vectors

  2017cites this paper
• Long-lived tissue resident HIV-1 specific memory CD8+ T cells are generated by skin immunization with live virus vectored microneedle arrays

  2017cites this paper
• Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo

  2017cites this paper
• Designing the Next-generation Oncolytic Vaccinia Virus

  2017cites this paper
• Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector–Host Interactions for Therapy

  2017cites this paper
• Adenovirus Vector Toxicity

  2017cites this paper
• Investigation of adenoviral immune neutralization and tropism for improved targeted gene delivery

  2017cites this paper
• Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.

  2016cites this paper
• The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model

  2016cites this paper
• Oncolytic Viral and Immunotherapy Models Combined with Strategies to Ameliorate Cancer Burden

  2016cites this paper
• Biodistribution and toxicity evaluation of sesbania mosaic virus nanoparticles in mice

  2016cites this paper
• Adenovirus-host interactions : implications for tropism and therapy

  2016cites this paper
• Viral chemistry: the chemical functionalization of viral architectures to create new technology.

  2016cites this paper
• Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours.

  2015cites this paper
• Targeting cancer with reovirus.

  2015cites this paper
• Aptamers as Enhancers of Oncolytic Virus Therapy

  2015cites this paper
• TMPRSS2 promoter driven enzyme-prodrug therapy for the treatment of PCa

  2015cites this paper
• Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer

  2015cites this paper
• Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs

  2015cites this paper
• The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications

  2014cites this paper
• Ad5/48 hexon oncolytic virus expressing sTGFβRIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases.

  2014cites this paper
• Traceless Bioresponsive Shielding of Adenovirus Hexon with HPMA Copolymers Maintains Transduction Capacity In Vitro and In Vivo

  2014cites this paper
• Efficient Uptake of Blood-Borne BK and JC Polyomavirus-Like Particles in Endothelial Cells of Liver Sinusoids and Renal Vasa Recta

  2014cites this paper
• VIRUSES AND HUMAN CANCER: FROM CAUSALITY TO CURE

  2014cites this paper
• Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors

  2014cites this paper
• Applications of coxsackievirus A21 in oncology

  2014cites this paper
• Transfection with Sodium Iodine Symporter Gene (NIS) and Future Applications with Radioiodine Treatment

  2014cites this paper
• The Targeted Transduction of MMP-Overexpressing Tumor Cells by ACPP-HPMA Copolymer-Coated Adenovirus Conjugates

  2014cites this paper
• Applications of coxsackievirus A21 in oncology

  2014cites this paper
• Applications of coxsackievirus A21 in oncology

  2014cites this paper
• Alternative approaches to the prevention of coronary In-stent restenosis

  2014cites this paper
• Systemic Image-Guided Liver Cancer Radiovirotherapy Using Dendrimer-Coated Adenovirus Encoding the Sodium Iodide Symporter as Theranostic Gene

  2013cites this paper
• Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo

  2013cites this paper
• Oncolytic virotherapy: the questions and the promise.

  2013cites this paper
• Enhanced Tumor Uptake and Penetration of Virotherapy Using Polymer Stealthing and Focused Ultrasound

  2013cites this paper
• Drug Delivery Systems for the Treatment of Ischemic Stroke

  2013cites this paper
• Selectively Replicating Oncolytic Adenoviruses Combined with Chemotherapy, Radiotherapy, or Molecular Targeted Therapy for Treatment of Human Cancers

  2013cites this paper
• Oncolytic virus therapy for cancer.

  2013cites this paper
• Oncolytic Virotherapy Oncolytic virus therapy for cancer

  2013cites this paper
• Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors

  2013cites this paper
• Development and characterization of a recombinant vesicular stomatitis virus (rvsv) for the treatment of glioblastoma

  2013cites this paper
• Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine

  2013cites this paper
• The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity.

  2013cites this paper
• Design, Characterization and Application of Amphipathic Peptides for siRNA Delivery

  2013cites this paper
• Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester.

  2013cites this paper
• SR-A and SREC-I are Kupffer and endothelial cell receptors for helper-dependent adenoviral vectors.

  2013cites this paper
• Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy.

  2012cites this paper
• Self-assembly of biodegradable copolyester and reactive HPMA-based polymers into nanoparticles as an alternative stealth drug delivery system

  2012cites this paper
• The effect of arti fi cial lipid envelopment of Adenovirus 5 ( Ad 5 ) on liver detargeting and hepatotoxicity

  2012cites this paper
• Polymer coatings for delivery of nucleic acid therapeutics.

  2012cites this paper
• Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.

  2012cites this paper